In a meta - analysis
of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
Originally described in the 1980s, the potential of oligonucleotides as therapeutic agents
spawned hundreds of clinical trials and billions of dollars of investment in companies developing these therapeutics without generating successful products.
Since every woman has to go through menopause at some stage in her life,
hundreds of clinical trials and research studies are continuously being conducted in order to find the most appropriate method for these women to manage the symptoms they experience during this time in their lives.